Intuitive Surgical reported Q1 2026 results that exceeded expectations, driven by continued growth in procedure volumes and improved operational leverage. Complementing this momentum, the company completed a strategic acquisition in early 2026 to internalize key distribution channels across Europe, Latin America, and Asia, reducing dependency on third-party operators and enhancing sales efficiency. The business model, anchored by recurring revenues from instruments and services tied to its installed base of da Vinci systems, remains robust amid expanding surgical indications such as advanced cardiac procedures. Regulatory approvals and entrenched switching costs solidify Intuitive’s competitive moat, though potential risks include regulatory delays and emerging rivals. Upcoming milestones center on integration progress and new procedure launches.